| [1] Geng SJ, Liao FF, Dang WH, et al. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation. Exp Neurol. 2010;222(2):256-266.[2] Chapleau CA, Pozzo-Miller L. Divergent roles of p75NTR and Trk receptors in BDNF's effects on dendritic spine density and morphology. Neural Plast. 2012;2012:578057.[3] Lee R, Kermani P, Teng KK, et al. Regulation of cell survival by secreted proneurotrophins. Science. 2001;294(5548): 1945-1948.[4] Chu GK, Yu W, Fehlings MG. et al. The P75 neurotrophin receptor is essential for neuronal cell survival and improvement of functional recovery after spinal cord injury. Neuroscience. 2007;148(3):668-682.[5] Chen Y, Zeng J, Cen L,et al. Multiple roles of the P75 neurotrophin receptor in the nervous system. J Int Med Res. 2009;37(2):281-288.[6] Ba YC, Dai P, Zhou HL, et al. Spatiotemporal changes of NGF, BDNF and NT-3 in the developing spinal cords of embryonic chicken. Neurochem Res. 2010;35(2):273-278.[7] Brown A, Ricci MJ, Weaver LC.NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the rat.Exp Neurol. 2007;205(1):283-286.[8] Qian DX, Zhang HT, Cai YQ, et al. Expression of tyrosine kinase receptor C in the segments of the spinal cord and the cerebral cortex after cord transection in adult rats. Neurosci Bull. 2011;27(2):83-90.[9] Li HP, Liu Y, He XJ, et al. P75 neurotrophin receptor mRNA sequential expression and significance after Cauda equina compression in rats. Zhongguo Gu Shang. 2011;24(6): 509-513.[10] Sharma HS, Westman J. The Blood-Spinal Cord and Brain Barriers in Health and Disease. Academic Press.San Diego. 2004:1-617.[11] Ejstrup R, Kiilgaard JF, Tucker BA, et al. Pharmacokinetics of intravitreal glial cell line-derived neurotrophic factor: experimental studies in pigs. Exp Eye Res. 2010;91(6): 890-895.[12] Dijkhuizen PA, Hermens WT, Teunis MA, et al. Adenoviral vector-directed expression of neurotrophin-3 in rat dorsal root ganglion explants results in a robust neurite outgrowth response. J Neurobiol. 1997;33(2):172-184.[13] Obermair FJ, Schröter A, Thallmair M. Endogenous neural progenitor cells as therapeutic target after spinal cord injury. Physiology (Bethesda). 2008;23:296-304.[14] Aomar Millán M, Cortiñas Sáenz M, Delgado Tapia J, et al. Assessment of neurologic function and complications in a retrospective cohort of patients with acute spinal cord injury due to trauma treated with large-dose methylprednisolone. Rev Esp Anestesiol Reanim. 2011; 58(10):583-8.[15] Kim DH, Jahng TA. Continuous brain-derived neurotrophic factor (BDNF) infusion after methylprednisolone treatment in severe spinal cord injury. J Korean Med Sci. 2004;19(1): 113-122.[16] Arvanian VL, Manuzon H, Davenport M, et al. Combined treatment with neurotrophin-3 and LSD facilitates behavioral recovery from double-hemisection spinal injury in neonatal rats. J Neurotrauma. 2006;23(1):66-74.[17] Sharma HS. Selected combination of neurotrophins potentiate neuroprotection and functional recovery following spinal cord injury in the rat. Acta Neurochir Suppl. 2010;106: 295-300.[18] Lang EM, Asan E, Plesnila N, et al. Motoneuron survival after C7 nerve root avulsion and replantation in the adult rabbit: effects of local ciliary neurotrophic factor and brain-derived neurotrophic factor application. Plast Reconstr Surg. 2005; 115(7):2042-2050.[19] Donnelly EM, Strappe PM, McGinley LM, et al. Lentiviral vector-mediated knockdown of the neuroglycan 2 proteoglycan or expression of neurotrophin-3 promotes neurite outgrowth in a cell culture model of the glial scar.J Gene Med. 2010;12(11):863-872.[20] Cao Q, He Q, Wang Y, et al. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci. 2010;30(8): 2989-3001.[21] Deng LX, Hu J, Liu N,et al. GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury. Exp Neurol. 2011;229(2):238-250.[22] Kusano K, Enomoto M, Hirai T, et al. Transplanted neural progenitor cells expressing mutant NT3 promote myelination and partial hindlimb recovery in the chronic phase after spinal cord injury. Biochem Biophys Res Commun. 2010;393(4): 812-817.[23] Zhang L, Gu S, Zhao C, et al. Combined treatment of neurotrophin-3 gene and neural stem cells is propitious to functional recovery after spinal cord injury. Cell Transplant. 2007;16(5):475-481.[24] Brock JH, Rosenzweig ES, Blesch A, et al. Local and remote growth factor effects after primate spinal cord injury. J Neurosci. 2010;30(29):9728-9737.[25] Wang Y, Liu J, Xu C,et al. Bone Marrow Transplantation Combined with Mesenchymal Stem Cells Induces Immune Tolerance without Cytotoxic Conditioning. J Surg Res. 2011; 171(1):e123-131.[26] Koda M, Kamada T, Hashimoto M, et al. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord. Eur Spine J. 2007;16(12): 2206-2214.[27] Zhang W, Yan Q, Zeng YS, et al. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain Res. 2010; 1359: 256-271.[28] Gros T, Sakamoto JS, Blesch A, et al. Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials. 2010;31(26): 6719-6729.[29] Burdick JA, Ward M, Liang E, et al. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials. 2006;27(3):452-459.[30] Piantino J, Burdick JA, Goldberg D, et al. An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp Neurol. 2006;201(2):359-367.[31] Tsai EC, Dalton PD, Shoichet MS, et al. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials. 2006; 27(3): 519-533. [32] Johnson PJ, Tatara A, Shiu A, et al. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant. 2010;19(1):89-101.[33] Jiang H, Jin WL, Jin DD. et al. Neuroproctecfion of a neotype transactivating-brain-derived neurotrophic factor fusion protein with penetrating activity of blood-brain barrier. Zhonghua Yi Xue Za Zhi. 2011;91(25):1786-1790. [34] Wenjin W, Wenchao L, Hao Z,et al. Electrical stimulation promotes BDNF expression in spinal cord neurons through Ca(2+)- and Erk-dependent signaling pathways.Cell Mol Neurobiol. 2011;31(3):459-467.[35] Jang SW, Liu X, Yepes M, et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone.Proc Natl Acad Sci USA. 2010;107(6):2687-2692. |
